AliveCor Inc, Mountain View, California.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
JAMA Cardiol. 2019 May 1;4(5):428-436. doi: 10.1001/jamacardio.2019.0640.
For patients with chronic kidney disease (CKD), hyperkalemia is common, associated with fatal arrhythmias, and often asymptomatic, while guideline-directed monitoring of serum potassium is underused. A deep-learning model that enables noninvasive hyperkalemia screening from the electrocardiogram (ECG) may improve detection of this life-threatening condition.
To evaluate the performance of a deep-learning model in detection of hyperkalemia from the ECG in patients with CKD.
DESIGN, SETTING, AND PARTICIPANTS: A deep convolutional neural network (DNN) was trained using 1 576 581 ECGs from 449 380 patients seen at Mayo Clinic, Rochester, Minnesota, from 1994 to 2017. The DNN was trained using 2 (leads I and II) or 4 (leads I, II, V3, and V5) ECG leads to detect serum potassium levels of 5.5 mEq/L or less (to convert to millimoles per liter, multiply by 1) and was validated using retrospective data from the Mayo Clinic in Minnesota, Florida, and Arizona. The validation included 61 965 patients with stage 3 or greater CKD. Each patient had a serum potassium count drawn within 4 hours after their ECG was recorded. Data were analyzed between April 12, 2018, and June 25, 2018.
Use of a deep-learning model.
Area under the receiver operating characteristic curve (AUC) and sensitivity and specificity, with serum potassium level as the reference standard. The model was evaluated at 2 operating points, 1 for equal specificity and sensitivity and another for high (90%) sensitivity.
Of the total 1 638 546 ECGs, 908 000 (55%) were from men. The prevalence of hyperkalemia in the 3 validation data sets ranged from 2.6% (n = 1282 of 50 099; Minnesota) to 4.8% (n = 287 of 6011; Florida). Using ECG leads I and II, the AUC of the deep-learning model was 0.883 (95% CI, 0.873-0.893) for Minnesota, 0.860 (95% CI, 0.837-0.883) for Florida, and 0.853 (95% CI, 0.830-0.877) for Arizona. Using a 90% sensitivity operating point, the sensitivity was 90.2% (95% CI, 88.4%-91.7%) and specificity was 63.2% (95% CI, 62.7%-63.6%) for Minnesota; the sensitivity was 91.3% (95% CI, 87.4%-94.3%) and specificity was 54.7% (95% CI, 53.4%-56.0%) for Florida; and the sensitivity was 88.9% (95% CI, 84.5%-92.4%) and specificity was 55.0% (95% CI, 53.7%-56.3%) for Arizona.
In this study, using only 2 ECG leads, a deep-learning model detected hyperkalemia in patients with renal disease with an AUC of 0.853 to 0.883. The application of artificial intelligence to the ECG may enable screening for hyperkalemia. Prospective studies are warranted.
对于患有慢性肾脏病 (CKD) 的患者,高钾血症很常见,与致命性心律失常有关,而且通常无症状,而指南指导的血清钾监测却未得到充分利用。一种能够从心电图 (ECG) 无创筛查高钾血症的深度学习模型可能会提高对这种危及生命的疾病的检测能力。
评估深度学习模型在检测 CKD 患者心电图高钾血症中的性能。
设计、地点和参与者:使用来自明尼苏达州罗切斯特市梅奥诊所的 449380 名患者的 1576581 份心电图,对一个深度卷积神经网络 (DNN) 进行了训练。该 DNN 使用 2 个 (导联 I 和 II) 或 4 个 (导联 I、II、V3 和 V5) 导联进行训练,以检测血清钾水平为 5.5 mEq/L 或更低(如需将毫摩尔转换为毫当量,乘以 1),并使用明尼苏达州、佛罗里达州和亚利桑那州梅奥诊所的回顾性数据进行验证。验证包括 3 期或更高级别的 CKD 患者 61965 人。每位患者在记录心电图后 4 小时内抽取血清钾计数。数据分析于 2018 年 4 月 12 日至 2018 年 6 月 25 日进行。
使用深度学习模型。
接受者操作特征曲线下面积 (AUC) 以及灵敏度和特异性,以血清钾水平为参考标准。该模型在 2 个操作点进行评估,一个用于特异性和灵敏度相等,另一个用于灵敏度高(90%)。
在总计 1638546 份心电图中,55%(908000 份)来自男性。在 3 个验证数据集的高钾血症患病率从 2.6%(50099 例中 1282 例;明尼苏达州)到 4.8%(6011 例中 287 例;佛罗里达州)不等。使用导联 I 和 II,深度学习模型在明尼苏达州的 AUC 为 0.883(95%CI,0.873-0.893),在佛罗里达州为 0.860(95%CI,0.837-0.883),在亚利桑那州为 0.853(95%CI,0.830-0.877)。在 90%灵敏度的操作点,灵敏度为 90.2%(95%CI,88.4%-91.7%),特异性为 63.2%(95%CI,62.7%-63.6%)在明尼苏达州;灵敏度为 91.3%(95%CI,87.4%-94.3%),特异性为 54.7%(95%CI,53.4%-56.0%)在佛罗里达州;灵敏度为 88.9%(95%CI,84.5%-92.4%),特异性为 55.0%(95%CI,53.7%-56.3%)在亚利桑那州。
在这项研究中,使用仅 2 个心电图导联,深度学习模型检测到肾脏病患者的高钾血症,AUC 为 0.853 至 0.883。人工智能在心电图中的应用可能会实现高钾血症的筛查。需要进行前瞻性研究。